Read + Share
Amedeo Smart
Independent Medical Education
Hu B, Wiesehofer M, de Miguel FJ, Liu Z, et al. ASCL1 Drives Tolerance to Osimertinib in EGFR Mutant Lung Cancer in Permissive Cellular Contexts. Cancer Res 2024 Feb 15. doi: 10.1158/0008-5472.CAN-23-0438.PMID: 38359163
Email
LinkedIn
Facebook
Twitter
Privacy Policy